Camden National Files 8-K for Routine 'Other Event' on Jan 4
Ticker: CAC · Form: 8-K · Filed: 2024-01-05T00:00:00.000Z
Sentiment: neutral
Topics: corporate-governance, regulatory-filing, other-events
TL;DR
**Camden National filed a routine 8-K, no big news here.**
AI Summary
Camden National Corporation filed an 8-K on January 5, 2024, reporting an event that occurred on January 4, 2024. This filing is a routine disclosure of an 'Other Event' and 'Financial Statements and Exhibits,' indicating standard corporate actions rather than a major, market-moving announcement. For investors, this filing suggests business as usual, without immediate red flags or significant positive catalysts, meaning the stock's value is unlikely to be directly impacted by this specific filing.
Why It Matters
This filing is a standard disclosure, indicating that Camden National Corporation is adhering to SEC reporting requirements for general corporate events. It doesn't signal any immediate major changes for investors.
Risk Assessment
Risk Level: low — The filing is for 'Other Events' and 'Financial Statements and Exhibits,' which are typically routine and do not indicate significant new risks.
Analyst Insight
Given this is a routine 8-K filing for 'Other Events' and 'Financial Statements and Exhibits' without specific details of a material event, a smart investor would likely view this as standard compliance and not a trigger for immediate action. Further investigation into the specific exhibits, if any, would be needed to assess any potential minor impacts.
Key Numbers
- 20240104 — Date of earliest event reported (The date the event described in the 8-K occurred.)
- 20240105 — Filing date (The date the 8-K was filed with the SEC.)
- 001-13227 — SEC File Number (The SEC file number for Camden National Corporation.)
- 207-236-8821 — Business Phone Number (The primary contact number for Camden National Corporation.)
Key Players & Entities
- Camden National Corporation (company) — registrant of the 8-K filing
- Maine (company) — state of incorporation for Camden National Corporation
- 0000750686 (dollar_amount) — Central Index Key (CIK) for Camden National Corporation
- 01-0413282 (dollar_amount) — IRS Employer Identification No. for Camden National Corporation
- CAC (company) — Trading Symbol for Camden National Corporation's Common Stock
- The NASDAQ Stock M (company) — Exchange where Camden National Corporation's Common Stock is registered
FAQ
What was the specific date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 4, 2024, as stated in the 'Date of Report (date of earliest event reported): January 4, 2024' section.
What is the trading symbol for Camden National Corporation's Common Stock, and on which exchange is it registered?
The trading symbol for Camden National Corporation's Common Stock is CAC, and it is registered on The NASDAQ Stock M, as indicated under 'Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, without par value CAC The NASDAQ Stock M'.
What is the primary business address for Camden National Corporation?
The primary business address for Camden National Corporation is Two Elm Street, Camden, Maine 04843, as listed under 'Address of principal executive offices'.
Is Camden National Corporation considered an 'emerging growth company' according to this filing?
No, Camden National Corporation is not an 'emerging growth company,' as indicated by the unchecked box next to 'Emerging Growth Company' in the filing.
What are the specific items of information included in this 8-K filing?
This 8-K filing includes 'Other Events' and 'Financial Statements and Exhibits' under the 'ITEM INFORMATION' section.
Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 13 · Accepted 2024-01-05 16:14:24
Filing Documents
- cac-20240104.htm (8-K) — 29KB
- 0000750686-24-000003.txt ( ) — 179KB
- cac-20240104.xsd (EX-101.SCH) — 2KB
- cac-20240104_def.xml (EX-101.DEF) — 14KB
- cac-20240104_lab.xml (EX-101.LAB) — 27KB
- cac-20240104_pre.xml (EX-101.PRE) — 15KB
- cac-20240104_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. On January 5, 2024, Camden National Corporation (the "Company") announced that the board of directors has authorized the purchase of up to 750,000 shares of the Company's common stock, representing approximately 5.0% of the Company's issued and outstanding shares of common stock as of December 31, 2023. The new repurchase program became effective on January 4, 2024 and replaced the prior authority, which expired on January 3, 2024. The timing and exact amount of common stock repurchased under the repurchase program will depend on various factors, including market conditions, the Company's capital position and internal capital generation. The repurchase program does not include specific price targets; may be executed through open market purchases, accelerated share repurchase transactions or privately negotiated transactions, including utilizing Rule 10b5-1 programs; and may be suspended at any time.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) The following exhibits are filed with this Report: Exhibit No. Description 101 Cover Page Interactive Data - the cover page XBRL tags are embedded within the Inline XBRL document. 104 Cover Page Interactive Data File - Included in Exhibit 101.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: January 5, 2024 CAMDEN NATIONAL CORPORATION (Registrant) By: /s/ MICHAEL R. ARCHER Michael R. Archer Chief Financial Officer and Principal Financial & Accounting Officer